abil bacteria activ termin complement compon serum patient cystic fibrosi termin complement compon c3 c9 contribut host defens infect thi studi wa perform determin defect activ c3 c9 bacteria contribut pathogenesi recurr pulmonari infect cystic fibrosi bacteria wa incub serum patient cystic fibrosi 30 minut consumpt avail c3 wa sera control patient two patient chronic sever bronchiectasi base result present studi unlik defect activ c3 c9 contribut pathogenesi increas suscept pulmonari infect patient